UPDATED May 16, 2022
Potentially undervalued companies with a strong past performance and robust balance sheet.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
SQURPHARMASquare Pharmaceuticals | à§³221.40 | -1.2% | 2.6% | à§³196.3b | à§³313.67 | PS10.6x | E11.6% | 2.7% | Pharmaceuticals & Biotech | ||
BXPHARMABeximco Pharmaceuticals | à§³158.50 | -5.3% | -10.9% | à§³70.7b | à§³182.00 | PS12.3x | E12.3% | 2.2% | Pharmaceuticals & Biotech |